AU8241898A - New metalloproteinase inhibitors, their therapeutic use and process for the pro duction of the starting compound in the synthesis thereof - Google Patents

New metalloproteinase inhibitors, their therapeutic use and process for the pro duction of the starting compound in the synthesis thereof

Info

Publication number
AU8241898A
AU8241898A AU82418/98A AU8241898A AU8241898A AU 8241898 A AU8241898 A AU 8241898A AU 82418/98 A AU82418/98 A AU 82418/98A AU 8241898 A AU8241898 A AU 8241898A AU 8241898 A AU8241898 A AU 8241898A
Authority
AU
Australia
Prior art keywords
synthesis
new
therapeutic use
starting compound
metalloproteinase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82418/98A
Other languages
English (en)
Inventor
Maurizio Cirilli
Silvana D'alessio
Giovanni Di Stazio
Carlo Gallina
Enrico Gavuzzo
Cesare Giordano
Barbara Gorini
Fernando Mazza
Mario Paglialunga Paradisi
Gabriella Panini
Cinzia Piazza
Giorgio Pochetti
Vincenzo Politi
Antonio Sella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polifarma SpA
Consiglio Nazionale delle Richerche CNR
Original Assignee
Polifarma SpA
Consiglio Nazionale delle Richerche CNR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polifarma SpA, Consiglio Nazionale delle Richerche CNR filed Critical Polifarma SpA
Publication of AU8241898A publication Critical patent/AU8241898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU82418/98A 1997-07-17 1998-07-17 New metalloproteinase inhibitors, their therapeutic use and process for the pro duction of the starting compound in the synthesis thereof Abandoned AU8241898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM97A0441 1997-07-17
IT97RM000441A IT1296305B1 (it) 1997-07-17 1997-07-17 Inibitori di metalloproteinasi loro uso terapeutico e procedimento per la produzione del composto di partenza nella loro
PCT/IT1998/000202 WO1999003878A2 (en) 1997-07-17 1998-07-17 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis

Publications (1)

Publication Number Publication Date
AU8241898A true AU8241898A (en) 1999-02-10

Family

ID=11405183

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82418/98A Abandoned AU8241898A (en) 1997-07-17 1998-07-17 New metalloproteinase inhibitors, their therapeutic use and process for the pro duction of the starting compound in the synthesis thereof

Country Status (8)

Country Link
US (1) US6339160B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1019434B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3325017B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU8241898A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69818698T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2206955T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1296305B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1999003878A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
US6683165B1 (en) 1999-04-13 2004-01-27 Genome Therapeutics Corporation Human gene relating to respiratory diseases and obesity
GB9922577D0 (en) * 1999-09-23 1999-11-24 Center For Clinical & Basic Re Substituted phosphinate based peptide derivatives
WO2001078894A2 (en) * 2000-04-13 2001-10-25 Schering Corporation Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
WO2004032708A2 (en) * 2002-10-04 2004-04-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Vasoregulating compounds and methods of their use
JP5068428B2 (ja) * 2002-11-07 2012-11-07 アメリカ合衆国 血管新生および抗血管新生療法のための標的
BRPI0400284A (pt) * 2004-03-18 2005-11-01 Fundacao Oswaldo Cruz Uso de dm 43 e seus fragmentos como inibidor de metaloproteases de matriz
ATE509956T1 (de) * 2006-06-08 2011-06-15 Helmholtz Zentrum Muenchen Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie
GB0708507D0 (en) 2007-05-02 2007-06-13 Queen Mary & Westfield College Substituted phosphonates and their use
WO2017117130A1 (en) 2015-12-28 2017-07-06 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for inhibiting human immunodeficiency virus (hiv) release from infected cells
AU2019352741A1 (en) 2018-10-04 2021-05-06 Assistance Publique-Hôpitaux De Paris (Aphp) EGFR inhibitors for treating keratodermas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0401963A1 (en) 1989-04-13 1990-12-12 Beecham Group p.l.c. Phosphonopeptides with collagenase inhibiting activity
IT1242002B (it) * 1990-10-03 1994-02-02 Polifarma Spa Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido quello centrale
IT1277904B1 (it) * 1995-08-07 1997-11-12 Polifarma Spa Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego

Also Published As

Publication number Publication date
DE69818698D1 (de) 2003-11-06
WO1999003878A3 (en) 1999-04-01
WO1999003878A2 (en) 1999-01-28
DE69818698T2 (de) 2004-08-19
EP1019434A2 (en) 2000-07-19
JP2001525315A (ja) 2001-12-11
EP1019434B1 (en) 2003-10-01
IT1296305B1 (it) 1999-06-25
ITRM970441A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-07-17
ITRM970441A1 (it) 1999-01-17
ES2206955T3 (es) 2004-05-16
US6339160B1 (en) 2002-01-15
JP3325017B2 (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
ZA9811314B (en) Novel compounds and methods for synthesis and therapy
HUP0000210A3 (en) Heterocyclic compounds as metalloprotease inhibitors and use of them for producing pharmaceutical compisitions
IL133906A0 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
PL323710A1 (en) Reversible inhibitors of cysteinic protease
HUP0004306A3 (en) Benzamidine derivatives as factor xa inhibitors and process for their preparation
HUP9801283A3 (en) Use of tomoxetin for the production of medicaments against attention-deficit/hyperactivity disorder
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
HUP9800634A3 (en) P-amidino-benzylamide derivatives as thrombin inhibitors, intermediates and use thereof
ZA200108413B (en) Use of glycosyceramide synthesis inhibitors in therapy.
AU3868095A (en) Apolipoprotein-b synthesis inhibitors
HUP0001294A3 (en) Heterocycleketo hydrazide derivatives having protease inhibitor activity, process for their preparation and their use
AU3107795A (en) Inhibitors of the benzamidine type
ZA959084B (en) Apolipoprotein-b synthesis inhibitors
HUP0004491A3 (en) Isoqunolines as urokinase inhibitors process for producing them and use of them in the manufacture of a medicament
AU8241898A (en) New metalloproteinase inhibitors, their therapeutic use and process for the pro duction of the starting compound in the synthesis thereof
GR3032401T3 (en) Process for the manufacture of difluoromethane
ZA982326B (en) Improved process for the production of thiazolidine-diones and new thiazolidinediones.
AU1354199A (en) Process for the preparation of urea
IL138127A0 (en) Process for the synthesis of hiv protease inhibitors
AU7445100A (en) Sebum production inhibitors
AU5226798A (en) Use of paracetamol as depigmenting agent
EP0785786A4 (en) MICROBIAL SYNTHESIS OF HIV PROTEASE INHIBITORS
HUP9802645A3 (en) New metalloproteinase inhibitors, process for producing them, and pharmaceutical compositions containing them
HU9800472D0 (en) New benzoxazinedion derivatives, process for producing them and use of them
AU1913397A (en) Process for the manufacture of difluoromethane

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase